Drug Delivery Business provides news, editorial and technology coverage of medical technology companies that specialize in transporting and delivering pharmaceutical compounds in the human body.

2024年12月23日 · There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

2 天之前 · Trinity Biotech (Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system. Dublin, Ireland-based Trinity’s trial included 30 participants, primarily with type 1 diabetes. The company said it represents a significant milestone in ...

2025年1月17日 · The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Drug Delivery Business News Where medtech meets pharma. Telling the stories behind the devices that save lives. Since 2016, Drug Delivery Business News has provided daily coverage of the latest drug-delivery trends and research, including topics such as combination products, diabetes-care devices, drug-eluting stents, auto-injectors, nanotechnology-based drug delivery and more. Our readers ...

Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. Late last year, Embecta filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. This related to the company’s plans to discontinue its insulin patch pump program and restructure. […]

2022年7月19日 · From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some updates on some ...

Phillips Medisize parent company Molex announced today that it completed its acquisition of Vectura from a subsidiary of cigarette maker Philip Morris. The company says adding Vectura enables it to offer a wider range of formulation, device design, combination product development and manufacturing services. It acquires Vectura’s proprietary technology and combination product development ...

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology, Wall Street Beat Tagged With: Beta Bionics BD to close infusion and syringe pumps facility in Israel January 27, 2025 By Chris Newmarker

2023年7月20日 · Innovations in drug delivery never stop, and over the past 12 months or so a wide variety have been in the spotlight.